血嗜酸性粒细胞阳离子蛋白与嗜酸性粒细胞衍生神经毒素与成人哮喘不同表达及演变相关
基于EGEA研究,在941名成人中横断面分析显示,高ECP和高EDN水平均与当前哮喘相关(aOR分别为1.69和2.12)。在哮喘患者中,高EDN与哮喘发作、喘息、治疗使用及支气管高反应性相关,高ECP与高中性粒细胞计数相关。纵向分析显示,EGEA2时高EDN水平与持续性哮喘、夜间症状及喘息加重相关,提示EDN可能作为监测成人哮喘演变的生物标志物。
要点
- 高ECP和高EDN水平均与成人当前哮喘相关,EDN关联更强(aOR 2.12)。
- 高EDN水平与哮喘发作、喘息、治疗使用及支气管高反应性相关。
- 高EDN水平与持续性哮喘及夜间症状等哮喘演变相关。
核心结论
- EDN和ECP与成人哮喘不同表达相关,EDN可能是监测成人哮喘演变的潜在生物标志物。
研究设计与样本
- 基于EGEA研究的横断面分析纳入941名成人(43±16岁,39%患哮喘),纵向分析纳入817名成人。
- 血浆ECP和EDN水平通过ELISA测量,使用广义估计方程调整年龄、性别、吸烟状态和体重指数。
主要发现
- EGEA2时,高ECP和高EDN水平均与当前哮喘相关,aOR分别为1.69(95%CI 1.35-2.12)和2.12(95%CI 1.76-2.57)。
- 在哮喘患者中,高EDN水平与哮喘发作(aOR 1.50,95%CI 1.13-1.99)、喘息和呼吸困难(aOR 1.38,95%CI 1.05-1.80)、哮喘治疗使用(aOR 1.91,95%CI 1.37-2.68)及支气管高反应性(aOR 2.03,95%CI 1.38-2.97)相关。
- 高ECP水平与高中性粒细胞计数相关,并倾向于与慢性支气管炎相关。
- EGEA2时高EDN水平与持续性哮喘(aOR 1.62,95%CI 1.04-2.52)、夜间症状(aOR 2.19至3.57)、喘息和呼吸困难加重(aOR 1.97,95%CI 1.36-2.85)及夜间气短(aOR 1.44,95%CI 1.04-1.98)相关。
临床怎么用
- 成人哮喘患者可考虑检测血EDN水平以辅助评估哮喘活动性和演变风险。
- 高EDN水平提示需关注哮喘发作、夜间症状及持续性哮喘可能。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Eosinophil-derived neurotoxin (EDN) and eosinophil cationic protein (ECP) are proteins released by activated eosinophils whose role in adult asthma remains unclear. OBJECTIVE: To study associations between ECP, EDN and various asthma characteristics in adults from the Epidemiological Study on the Genetics and Environment of Asthma (EGEA). METHODS: Plasma ECP and EDN levels were measured by ELISA. Cross-sectional analyses were performed in 941 adults (43±16 years old, 39% with asthma) at EGEA2 (2003-2007). Longitudinal analyses investigated the associations between EDN level at EGEA2 and changes in asthma characteristics between EGEA2 and EGEA3 (2011-2013, n=817). We used generalised estimated equations adjusted for age, sex, smoking status and body mass index to take into account familial dependence. RESULTS: At EGEA2, both high ECP and EDN levels were associated with current asthma (adjusted OR (aOR) (95% CI): 1.69 (1.35-2.12) and 2.12 (1.76-2.57)). Among asthmatics, high EDN level was associated with asthma attacks (aOR: 1.50 (1.13-1.99)), wheezing and breathlessness (aOR: 1.38 (1.05-1.80)), use of asthma treatments (aOR: 1.91 (1.37-2.68)) and bronchial hyper-responsiveness (aOR: 2.03 (1.38-2.97)), even after further adjustment on ECP. High ECP level was associated with high neutrophil count and tended to be associated with chronic bronchitis. High EDN level at EGEA2 was associated with persistent asthma (aOR: 1.62 (1.04-2.52)), nocturnal symptoms (aOR from 2.19 to 3.57), worsening wheezing and breathlessness (aOR: 1.97 (1.36-2.85)) and nocturnal shortness of breath (aOR: 1.44 (1.04-1.98)) between EGEA2 and EGEA3. CONCLUSIONS: EDN and ECP were associated with different asthma expression in adults. EDN could be a potential biomarker to monitor asthma evolution in adults.
引用
- Granger V, Zerimech F, Arab J, et al. Blood eosinophil cationic protein and eosinophil-derived neurotoxin are associated with different asthma expression and evolution in adults. Thorax. 2021. PMID: 34615736. doi:10.1136/thoraxjnl-2021-217343
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。